We are thrilled to announce that Qure.ai, a pioneering health tech company, has successfully raised $7,500,000 in funding to enhance our mission of making healthcare more accessible and equitable worldwide. Our innovative approach harnesses the power of deep learning and Artificial Intelligence (AI) to improve the identification and management of critical health conditions such as Tuberculosis (TB), Lung Cancer, and Stroke. With this new influx of capital, we aim to further develop our AI-driven solutions, which not only assist clinicians in making swift, accurate diagnoses but also streamline treatment planning processes. This strategic funding will bolster our research and development initiatives, allowing us to refine our algorithms and expand our technological capabilities to serve a broader patient base. In addition, it will support our ongoing partnerships with pharmaceutical and medical device companies, accelerating advancements in healthcare delivery. At Qure.ai, we believe that every individual, regardless of their geographical or socio-economic situation, deserves access to quality healthcare. This funding marks a significant step forward in our commitment to empowering healthcare professionals and ultimately improving patient outcomes across the globe. We are excited to embark on this next chapter of growth, driven by our passion for innovation and our unwavering dedication to transforming the healthcare landscape. Stay tuned for more updates as we continue our mission to bridge the gap in healthcare accessibility through AI technology!








